The Taiwan Ministry of Health and Welfare has delivered registration for Guerbet's contrast media kit Vectorio.
Vectorio is a mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid plus an anticancer drug during transarterial chemoembolization procedures. It is designed for adults with intermediate-stage hepatocellular carcinoma.
The system received the European CE Mark in August 2017 and officially launched in September 2017. It is currently registered in 25 countries.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
